Psychologists in Clemson, SC Accepting Medicare
9 Psychologists found. Showing 1 - 9
 Dr. Ora Dempsey White, PHD, LP Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 735 Mcmillan Road, Clemson, SC 29634 Phone: 864-656-2451 |
 Mary Ashley Allen, LPC-A Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 1011 Tiger Blvd Ste 610, Clemson, SC 29631 Phone: 864-633-7937 |
Dr. Kevin Mckinley Tabb Jr. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 735 Mcmillan Rd, Clemson, SC 29634 Phone: 846-656-0476 |
Dr. Heidi Zinzow, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 400 College Ave Ste 4, Clemson, SC 29631 Phone: 864-656-4376 |
Dr. Nadine Grissett Mccallum, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 398 College Ave, Clemson, SC 29631 Phone: 864-985-3305 |
Elizabeth Hiller Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 102 Creekview Dr, Clemson, SC 29631 Phone: 843-697-5783 |
Marie Murray O'hara, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 400 College Ave Ste 4, Clemson, SC 29631 Phone: 864-903-2414 |
Dr. George Atkinson, PH.D. Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 226 Frontage Rd, Clemson, SC 29631 Phone: 864-506-1173 |
Dr. Rhonda Buford, PH.D. Psychologist - Mental Retardation & Developmental Disabilities Medicare: Not Enrolled in Medicare Practice Location: 398 College Ave, Clemson, SC 29631 Phone: 864-650-3098 Fax: 864-653-4129 |
News Archive
Interprofessional collaboration may help improve patients' access to HIV testing and primary care
Getting better access to testing and proper primary care for individuals vulnerable to HIV could be as simple as a telephone call or email among health providers.
COVID-19 mortality linked to differences in trust and income inequality
rust in public institutions is linked to fewer COVID-19 deaths, but trust and belonging to groups is associated with more deaths, according to a wide-ranging, McGill-led study of 30-day COVID-19 mortality rates in 84 countries.
Two-gene DNA urine test for prostate cancer
In the current debate sparked by the recent USPSTF recommendation on PSA screening, it is clear that better biomarkers than PSA are urgently needed. One new biotechnology that may go a long way in detecting only prostate cancer and reducing unnecessary prostate cancer biopsies and possible subsequent overtreatment, is the development of a new urine test for prostate cancer.
Labopharm launches INTELLITAB abuse and misuse-deterrent technology platform
Labopharm Inc. today introduced INTELLITAB(TM), the brand name for its proprietary abuse and misuse-deterrent technology platform. The INTELLITAB(TM) platform, which can deliver one or more therapeutic drugs in combination over periods of up to 24 hours, has the potential to provide a patient with a controlled release medication while minimizing the risk of intentional abuse or accidental misuse.
› Verified 7 days ago
Pharmacists
Counselors
Occupational Therapists
Dentists
Psychologists
Clinical Social Workers